Discover 62 paid clinical trials in Bowling Green, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 62
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Bowling Green KY, Lexington KY, Knoxville TN,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & Responsive
A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
for
Elevated Blood Pressure, Hypertension
Location: Bowling Green KY, Knoxville TN, Chicago IL,
Sponsor: Zona Health, Inc
Sex: All
Age: 22+
Code: NCT06843577
Recruiting
Active & Responsive
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
for
Arthritis, Rheumatoid
Location: Bowling Green KY, Huntsville AL, Tupelo MS,
Sponsor: Crescendo Bioscience
Sex: All
Age: 18 - 70+
Code: NCT02832297
Recruiting
Active & Responsive
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Bowling Green KY, Nashville TN, Mason OH,
Sponsor: Apogee Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07003425
Phase2, Recruiting
Active & Responsive
Phase 2b Study of EVO756 in Adults With Atopic Dermatitis
for
Atoptic Dermatitis
Location: Bowling Green KY, Murfreesboro TN, Clarksville IN,
Sponsor: Evommune, Inc.
Sex: All
Age: 18+
Code: NCT07150845
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Bowling Green KY, Smyrna TN, Myrtle Beach SC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
for
Atopic Dermatitis
Location: Bowling Green KY, Goodlettsville TN, Owensboro KY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 12+
Code: NCT07006792
Recruiting
Active & Responsive
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis, Atopic, Dermatitis, AD, Eczema
Location: Bowling Green KY, Clarksville IN, Indianapolis IN,
Sponsor: Aclaris Therapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT07011706
Phase2, Recruiting
Active & Responsive
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)